Physician profile
Ralph R Romaker
NPI 1952380727
$837.64
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $609 · 2020: $97.51 · 2021: $131.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $209.56 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $150.78 | 2019 | |
| Amgen INC. | $82.85 | 2019-2021 | |
| Novo Nordisk INC | $75.95 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $51.60 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $35.68 | 2019 | |
| Allergan, INC. | $32.89 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.13 | 2019 | |
| Novartis Pharmaceuticals Corporation | $23.81 | 2019 | |
| Ironshore Pharmaceuticals INC. | $19.44 | 2019 | |
| Cardiovascular Systems INC. | $18.62 | 2020 | |
| Amarin Pharma, INC. | $17.22 | 2019 | |
| Abbvie INC. | $16.11 | 2021 | |
| Sanofi-Aventis U.S. LLC | $15.58 | 2019 | |
| Daiichi Sankyo INC. | $13.27 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $12.34 | 2019 | |
| Medtronic Vascular, INC. | $12.00 | 2019 | |
| Kci USA, INC. | $10.97 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $10.84 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Romaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.